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Abstract
In Saccharomyces cerevisiae, the essential mismatch repair (MMR) endonuclease Mlh1-Pms1 forms foci promoted by Msh2-
Msh6 or Msh2-Msh3 in response to mispaired bases. Here we analyzed the Mlh1-Mlh2 complex, whose role in MMR has
been unclear. Mlh1-Mlh2 formed foci that often colocalized with and had a longer lifetime than Mlh1-Pms1 foci. Mlh1-Mlh2
foci were similar to Mlh1-Pms1 foci: they required mispair recognition by Msh2-Msh6, increased in response to increased
mispairs or downstream defects in MMR, and formed after induction of DNA damage by phleomycin but not double-
stranded breaks by I-SceI. Mlh1-Mlh2 could be recruited to mispair-containing DNA in vitro by either Msh2-Msh6 or Msh2-
Msh3. Deletion of MLH2 caused a synergistic increase in mutation rate in combination with deletion of MSH6 or reduced
expression of Pms1. Phylogenetic analysis demonstrated that the S. cerevisiae Mlh2 protein and the mammalian PMS1
protein are homologs. These results support a hypothesis that Mlh1-Mlh2 is a non-essential accessory factor that acts to
enhance the activity of Mlh1-Pms1.
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Introduction
DNA mismatch repair (MMR) recognizes single base and
insertion/deletion mispairs generated by errors in DNA replica-
tion and some forms of chemically damaged bases [1–5]. Both
types of errors can lead to mutations if uncorrected. Arguably, the
best understood MMR system is the Escherichia coli methyl-directed
MMR system where mispair excision is targeted to the transiently
unmethylated newly synthesized DNA strand before Dam
methylase acts on the newly synthesized strand. MMR is initiated
by the MutS homodimer, which directly recognizes mispaired
bases in DNA. After mispair recognition, MutS recruits the MutL
homodimer, which promotes the MutH-mediated cleavage of the
unmethylated strand at hemi-methylated GATC sites. The MutH-
generated strand discontinuity (nick) functions as the initiation site
for an excision reaction that results in the degradation of a stretch
of the newly synthesized strand followed by its resynthesis.
However, there are other bacteria that lack MutH and do not
use DNA methylation for strand discrimination [6–8]. In
eukaryotes, the early steps of MMR are conserved with those in
E. coli [1,3–5] with the partially redundant MutS-related
complexes, the Msh2-Msh6 and Msh2-Msh3 heterodimers,
recognizing mispairs followed by recruitment of MutL-related
complexes. Genetic evidence in the yeast Saccharomyces cerevisiae
indicates that the Mlh1-Pms1 heterodimer (called MLH1-PMS2 in
humans) is the primary MutL homolog complex that functions in
promoting post-replication MMR [5]. In contrast to E. coli, the
steps during MMR following the recruitment of the MutL
homologs have remained poorly understood in eukaryotes and
other organisms that lack methyl-directed MMR. Recent exper-
iments in S. cerevisiae have indicated that MMR proteins are
coupled to DNA replication and have demonstrated the existence
of a short window of time after DNA is replicated during which
MMR has to initiate [2]. These and other results suggest that some
aspect of the DNA replication intermediates themselves may play
a role in mediating strand discrimination in organisms that lack
methyl-directed MMR [2,9].
Most eukaryotes encode multiple MutL homologs that function
as heterodimers. Mlh1-Pms1 (called MLH1-PMS2 in humans)
possesses an endonuclease activity that can introduce single-
stranded nicks into double-stranded DNA, suggesting that Mlh1-
Pms1 functions as the equivalent of a combination of both the
bacterial MutL and MutH proteins [10–12]. This endonuclease
activity is required for MMR in vivo as well as for suppression of
homeologous recombination and responses to DNA methylating
agents [10,13–15]. This endonuclease activity is also present in
MutL homologs from bacteria lacking methyl-directed MMR [16–
20].
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S. cerevisiae encodes two additional MutL complexes, Mlh1-Mlh3
and Mlh1-Mlh2. Mlh1-Mlh3 plays only a minor role during
MMR [21–23] but plays a major role in the resolution of
recombination intermediates during meiosis [24–26]. Mlh3
contains the conserved metal-binding motif that is required for
the endonuclease activity of Pms1, and mutations affecting this
motif in MLH3 cause defects in MLH3-dependent MMR and
meiotic crossing over [27]; consistent with this, the Mlh1-Mlh3
complex has recently been directly shown to have endonuclease
activity [28,29]. Mlh1-Mlh2 is more poorly understood than either
Mlh1-Pms1 or Mlh1-Mlh3 [22,25,30–32]. Mlh2 lacks the metal
binding motif present in Pms1 and Mlh3, and in most studies
reported, deletion of MLH2 causes a weak or no mutator
phenotype, and the results of double mutant analysis have been
taken to suggest a partial redundancy between MLH2 and MLH3
in MSH3-dependent MMR [22]. It has also been reported that
deletion of MLH2 increases the frequency of reversion of the
lys2DA746 frameshift mutation reporter due to the formation of
large deletions [22]. Deletion of MLH2 does not affect meiotic
crossing over or meiotic MMR, unlike deletion of MLH3 or PMS1
[25,31]. The mlh2D mutation does increase the frequency of gene
conversion events, suggesting a partial role for Mlh2 in preventing
heteroduplex formation, but not in subsequent mismatch correc-
tion; this property is unique among the S. cerevisiae MMR genes
[25,31]. Consistent with the idea that Mlh2 plays a role in
recombination, simultaneous deletion of PMS1, MLH2 and MLH3
was required to cause defects in a mitotic heteroduplex rejection
assay equivalent to that caused by an mlh1D mutation [32]. An
mlh2D mutation as well as deletions of MSH2, MSH3, MSH6 and
MLH1 but not PMS1 have also been reported to cause a modest
increase in resistance to some DNA damaging agents like cisplatin,
reminiscent of that seen in human and mouse cells [30]. However,
it is unclear how MLH2 contributes to either recombination or
MMR and why loss of Mlh2 only results in weak phenotypes.
Here, we employ live cell imaging in S. cerevisiae, complemented
by genetic and biochemical assays, to analyze Mlh2 function in
MMR. A similar approach applied to Pms1 previously revealed
that the accumulation of Pms1 foci can be used to distinguish
between genetic defects that affect events prior to Mlh1-Pms1
loading and those affecting downstream steps [33]. We found that
Mlh2 formed nuclear foci similar to Pms1, whereas Mlh3 did not.
Mlh2 foci partially colocalized with Pms1 foci and were dependent
on MSH2, MSH6, and MLH1 but not MSH3. Mlh2 foci increased
in abundance in strains with increased mispair formation and in
strains containing mutations that disrupt downstream steps in
MMR similarly to what was previously observed for Pms1 foci
[33]. In vitro, Mlh1-Mlh2 was recruited to mispair-containing DNA
by both Msh2-Msh6 and Msh2-Msh3. Deletion ofMLH2 caused a
synergistic increase in mutation rates when combined with a
deletion of MSH6 or a promoter substitution that reduced the
expression of Pms1; by contrast, no synergy was observed when
deletion ofMLH2 was combined with deletions ofMSH3 or EXO1.
Together, these data support the hypothesis that MLH2 encodes a
homolog of MutL that functions in conjunction with Mlh1 as a
MMR accessory factor whose roles become increasingly important
under conditions when other MMR components are limiting.
Results
Pms1 and Mlh2, but not Mlh3, form nuclear foci
We recently visualized Pms1 in live S. cerevisiae cells and
demonstrated that Mlh1-Pms1 foci are intermediates in MMR
[33]. To gain insight into the roles of Mlh1-Mlh2 and Mlh1-Mlh3,
we integrated a cassette encoding a 46GFP tag at the 39 end of the
chromosomal MLH2 or MLH3 genes. Live cell imaging of these
strains revealed that Mlh2-46GFP formed nuclear foci similar to
those observed for Pms1-46GFP in ,8% of unsynchronized cells
(Figure 1A and B). Mlh2-46GFP foci were almost exclusively
observed in small budded cells, characteristic of cells in S-phase
(Figure 1C). The observation that the Mlh2 foci visualized using
different tags (46GFP or a monomer tdTomato tag) were similar
in number and appearance (Figure 1; see below) indicate that the
fluorescent tags do not contribute to focus formation. In contrast
to Mlh2-46GFP, few if any cells had Mlh3-46GFP foci
(Figure 1B). The reason for the lack of Mlh3 foci is unclear, but
this could indicate a limited role of Mlh3 in MMR or that the
levels of Mlh3 at repair sites were too low to visualize.
To test if Mlh2 localizes to the same MMR intermediates as
Pms1, we examined colocalization of Mlh2-tdTomato with Pms1-
46GFP by live cell imaging. Interestingly, the Pms1 and Mlh2 foci
partially colocalized, with ,50% of Pms1 foci showing colocaliza-
tion with Mlh2 foci at the limit of resolution of deconvolution
microscopy (Figure 1D and E). To further examine the
relationship between the Pms1 and Mlh2 foci, image stacks were
taken at one-minute intervals to observe the localization of Pms1
and Mlh2 foci over time. We analyzed 50 cases where we could
follow the formation, retention for at least two images, and
disappearance of an Mlh2 or Pms1 focus. In agreement with the
single images, approximately half (21/50, 42%) of the foci
displayed colocalization between Pms1 and Mlh2 at some point
during their lifetimes (Figure 1F), 36% (18/50) were Pms1 foci
with no colocalization of Mlh2, and 22% (11/50) were Mlh2 foci
with no colocalization of Pms1.
For the 21 cases of colocalization observed by time-lapse
imaging, Pms1 and Mlh2 first appeared within the same frame for
the majority of events (13/21), indicating that both proteins were
recruited to the same site within the one minute temporal
resolution of the imaging (Figure 1F, bottom). In 3/21 events, a
Pms1 focus preceded the colocalized Mlh2 focus, and in the
remaining 5/21 events, the Mlh2 focus preceded the colocalized
Pms1 focus. Interestingly, Mlh2 foci frequently persisted after the
colocalized Pms1 was no longer detectable (11/21 cases); the Pms1
Author Summary
Lynch syndrome (hereditary nonpolyposis colorectal can-
cer or HNPCC) is a common cancer predisposition
syndrome. In this syndrome, predisposition to cancer
results from increased accumulation of mutations due to
defective mismatch repair (MMR) caused by a mutation in
one of the human mismatch repair genes MLH1, MSH2,
MSH6 or PMS2. In addition to these genes, various DNA
replication factors and the excision factor EXO1 function in
the repair of damaged DNA by the MMR pathway. In
Saccharomyces cerevisiae, the MLH2 gene encodes a MutL
homolog protein whose role in DNA mismatch repair has
been unclear. Here, we used phylogenetic analysis to
demonstrate that the S. cerevisiae Mlh2 protein and the
mammalian Pms1 protein are homologs. A combination of
genetics, biochemistry and imaging studies were used to
demonstrate that the Mlh1-Mlh2 complex is recruited to
mispair-containing DNA by the Msh2-Msh6 and Msh2-
Msh3 mispair recognition complexes where it forms foci
that colocalize with Mlh1-Pms1 foci (note that scPms1 is
the homolog of hPms2) and augments the function of the
Mlh1-Pms1 complex. Thus, this work establishes the Mlh1-
Mlh2 complex as a non-essential accessory factor that
functions in MMR.
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Figure 1. Mlh2 forms foci that partially colocalize with Pms1. (A) Images of cells expressing Pms1-46GFP or Mlh2-46GFP and Nic96-mCherry
as a marker of the nuclear pore complex reveal the presence of nuclear Pms1 and Mlh2 foci. (B) Quantitation of Mlh2-46GFP, Pms1-46GFP, and Mlh3-
46GFP foci. Error bars indicate the standard error of the mean (SEM), and ‘‘n’’ indicates the number of cells examined. (C) Distribution of Mlh2-46GFP
foci according to bud size: no bud or small (,1.5 mm), medium (1.5–3 mm), or large (.3 mm) budded cells. ‘‘n’’ indicates the number of cells
examined. (D) Images of cells expressing Mlh2-tdTomato and Pms1-46GFP reveal foci that contain both proteins as well as foci containing only one
of them. (E) Quantitation of Pms1 foci and Pms1 foci that colocalize with Mlh2. (F) Time-lapse images of cells with colocalized Mlh2-tdTomato and
Pms1-46GFP foci at one-minute intervals. White arrowheads indicate the start of colocalization and yellow arrowheads indicate Mlh2-tdTomato foci
that persist after loss of the Pms1-46GFP signal.
doi:10.1371/journal.pgen.1004327.g001
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foci were usually visible for 1 to 4 min, whereas the Mlh2 foci were
visible for up to 7 min (average = 4 min) after the associated Pms1
focus was no longer detected (11/21 cases, Figure 1F). In the
remaining 10 cases, the colocalized Pms1 and Mlh2 foci
disappeared at the same time. Strikingly, Pms1 foci were never
present after the disappearance of Mlh2, suggesting that Mlh2
frequently marks the site of Pms1 foci and likely the site of MMR
after Pms1 has been removed.
Mlh2 foci behave similarly to Pms1 foci that are MMR
intermediates
In our previous study [33], we identified Pms1 foci as an MMR
repair intermediate based on the following observations: (i) the
formation of the Pms1 foci depended on mispair recognition by
Msh2-Msh6 or Msh2-Msh3; (ii) the abundance of Pms1 foci
increased with increasing levels of mispaired bases; and (iii) Pms1
foci increased in abundance in cells defective in MMR at steps that
were downstream of recruitment of Mlh1-Pms1 [33]. Given the
partial colocalization of Pms1 and Mlh2, we investigated Mlh2 foci
by performing the same set of perturbations used to analyze Pms1
foci. Deletion of MSH2, which eliminates the Msh2-Msh3 and
Msh2-Msh6 mispair recognition complexes, completely abolished
Mlh2 foci (Figure 2A). Similarly, other mutations that disrupted
mispair recognition also eliminated Mlh2 foci (Figure 2A),
including the msh3D msh6D double mutation that eliminates both
the Msh2-Msh3 and Msh2-Msh6 complexes and the msh3D msh6-
F337A double mutation that eliminates Msh2-Msh3 and elimi-
nates mispair binding by Msh2-Msh6 [34]. Deletion of MSH6
alone also greatly reduced the number of Mlh2 foci, whereas
deletion of MSH3 had no effect, suggesting that the majority of
Mlh2 foci were dependent upon Msh2-Msh6 but not Msh2-Msh3
(Figure 2A). The DNA polymerase epsilon and delta active site
mutations (pol2-M644G and pol3-L612M, respectively) [35,36] or a
mutation causing a defect in the 39-59-exonuclease activity of DNA
polymerase delta (pol3-01) [37], all of which increase the level of
misincorporated bases, greatly increased the abundance of Mlh2
foci (Figure 2B). Deletion of EXO1, which encodes the 59-39
exonuclease that participates in the mispair excision reaction,
increased the percentage of nuclei with Mlh2 foci to ,50%
(Figure 2A). Together, these results mirror what was previously
observed for Pms1 foci, with the one notable exception that Pms1
foci were substantially increased and not decreased in an msh6D
mutant suggesting that Pms1 and Mlh2 differ in their ability to be
recruited by Msh2-Msh6 and Msh2-Msh3 in vivo [33].
We next examined the interdependencies of Pms1 and Mlh2 on
their ability to form foci. Mlh2 has been shown to interact with
Mlh1, but not with Pms1 or Mlh3, by yeast two-hybrid and
affinity-capture mass spectrometry [25,38–40], indicating the
existence of an Mlh1-Mlh2 heterodimer that is distinct from
Mlh1-Pms1 and Mlh1-Mlh3 heterodimers. Consistent with this,
deletion of MLH1 eliminated the vast majority of Mlh2 foci
(Figure 2A). Deletion of MLH2 had no effect on the number of
Pms1 foci (Figure 2C). In contrast, deletion of PMS1 drastically
increased the percentage of cells containing Mlh2 foci to ,95%
(Figure 2D). This increase in Mlh2 foci could either be due to
increased formation of the Mlh1-Mlh2 complex because of loss of
competition for the Mlh1 partner protein by Pms1 or due to loss of
Mlh1-Pms1 endonuclease activity and the consequent inhibition of
downstream steps in MMR. To differentiate between these two
possibilities, we measured the frequency of Mlh2 foci in cells
containing the endonuclease active site pms1-E707K mutation that
results in expression of an endonuclease-defective Mlh1-Pms1
complex. We observed a similar increase in the number of Mlh2
foci in pms1D and pms1-E707K mutant cells (Figure 2D), suggesting
that the increase in Mlh2 foci in pms1D cells is likely due to the
inhibition of downstream steps in MMR. The high levels of Mlh2
foci seen in the pms1D mutant were completely abolished by an
msh2D mutation (Figure 2D), confirming that the increased
recruitment of Mlh1-Mlh2 into foci in cells lacking Pms1 was
dependent on Msh2.
Mlh2 and Pms1 foci are increased by phleomycin
treatment but are not present at a double-strand break
generated by the I-SceI endonuclease
In human cells, Mlh1 and other MMR components are
recruited to sites where DNA damage has been induced by UV-
laser micro-irradiation [41–43]. This has been interpreted as the
recruitment of MutL homolog complexes to double-strand breaks
(DSBs). Consistent with these observations, treatment of S. cerevisiae
cells with the radiomimetic drug phleomycin greatly increased the
percentage of cells containing Pms1 and Mlh2 foci (,5-fold and
,3-fold, respectively) (Figure 3A). This was unlikely to be the
result of simply activating the DNA damage response (DDR)
because treatment with hydroxyurea, which also activates the
DDR by causing replication fork stalling by depleting dNTP pools,
did not cause an increase in the abundance of Pms1 or Mlh2 foci
(Figure 3A). As with foci formed in untreated cells, foci induced by
phleomycin treatment were not observed in msh2D strains.
To determine if the Msh2-dependent Pms1 and Mlh2 foci were
formed at DSBs and not other types of DNA lesions generated
during phleomycin treatment, we investigated the recruitment of
Pms1 and Mlh2 to a site-specific DSB generated by a galactose-
inducible I-SceI endonuclease. The DSB was generated adjacent to
a tandem array of tetO sequences on chromosome V that was
marked by expression of TetR-mRFP1 [44]. Cells expressing
Pms1-46GFP, Mlh2-46GFP, or Mre11-GFP (as a positive
control) were monitored before and after the addition of galactose
to induce the DSB. Consistent with published results [45], Mre11
rapidly formed foci that colocalized with the tetO array (Figure 3B
and C). In contrast, neither Pms1 nor Mlh2 formed foci that
colocalized with the tetO array. These results suggest that the
recruitment of Pms1 and Mlh2 to lesions induced by phleomycin
(and the similar recruitment of mammalian MMR proteins to the
sites of laser micro-irradiation) may not be due to recognition of
DSBs but rather due to recognition of the other types of DNA
damage induced by these treatments that might mimic mispaired
bases.
MLH2 suppresses frameshift mutations when other MMR
components are limiting
We next investigated the effects of deleting MLH2 on MMR
using the hom3-10 and lys2-10A frameshift reversion and CAN1
forward mutation rate assays (Table 1A). Deletion of MLH2 alone
did not cause a significant increase in mutation rate in either the
frameshift reversion or forward mutation assays, in agreement with
previous work [22]. We next tested if the mlh2D mutation
exacerbated the defects caused by mutations in other MMR
genes. The mlh2D msh3D or mlh2D exo1D double mutant strains did
not exhibit mutation rates that were higher than the mutation
rates of the single mutants. In contrast, the mlh2D msh6D double
mutant strain exhibited a synergistic increase in the hom3-10 and
lys2-10A frameshift reversion assays but not in the CAN1 forward
mutation assay that, in addition to frameshift mutations, detects
base substitution mutations and other kinds of mutations [46].
Although the frameshift reversion rates of the mlh2D msh6D double
mutant were higher than that of the respective single mutants, the
rates were still substantially lower than caused by the msh3D msh6D
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Figure 2. Mutations that perturb the abundance of Pms1 foci also perturb the abundance of Mlh2 foci. (A) The percentages of nuclei
containing Mlh2 foci were quantified in strains containing mutations in MMR genes or (B) genes encoding the catalytic subunits of the DNA
polymerases Pol2 and Pol3. (C) Quantification of the percentages of nuclei containing Pms1 foci in an mlh2D strain. (D) Quantification of the
percentages of nuclei containing Mlh2 foci in strains containing the pms1D mutation, the pms1D mutation in combination with an msh2D mutation
or the endonuclease active site pms1 mutation pms1-E707K. Error bars indicate the SEM, and ‘‘n’’ indicates the numbers of cells examined.
doi:10.1371/journal.pgen.1004327.g002
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double mutation that eliminates mispair recognition and causes a
complete MMR defect. The combination of the specificity of
MLH2 for suppressing frameshift mutations and synergy of the
mlh2D mutation with the msh6D mutation but not with the msh3D
mutation suggests that MLH2 contributes preferentially to MSH3-
dependent MMR.
Given the results of the Mlh2 localization studies, we
hypothesized that Mlh2 becomes more important for MMR
under conditions where the major MutL-related complex Mlh1-
Pms1 is limiting. To test this idea, we took advantage of the
previously reported tetracycline repressible system [47] to regulate
Pms1 expression (tetO2 promoter) in a doxycycline-dependent
manner. After titrating doxycycline, we found that 10 mg/ml of
doxycycline resulted in partial downregulation of Pms1 protein
expression (Figure S1) and a weak MMR defect in the frameshift
reversion assays but not in the CAN1 forward mutation assay
(Table 1B). Consistent with the hypothesis, we observed a
synergistic increase in the mutation rate in the frameshift reversion
assays when the mlh2D mutation was combined with reduced
expression of Pms1. Thus, Mlh2 becomes more important for
MMR when the level of Pms1 is reduced, suggesting that Mlh2
normally plays an accessory role in MMR.
Mlh1-Mlh2 is recruited to mispair-containing DNA by
Msh2-Msh6 and by Msh2-Msh3 in vitro
The genetics of Mlh2 foci formation suggested that Mlh1-Mlh2
is primarily recruited to mispair-containing DNA by Msh2-Msh6
(Figure 2A), whereas the genetics of frameshift mutation reversion
suggested that MLH2 functions primarily in an MSH3-dependent
pathway (Table 1A), suggesting that Mlh2 can function in
conjunction with either Msh2-Msh6 or Msh2-Msh3 depending
on the assay tested. To address this possibility, we purified the S.
cerevisiae Mlh1-Mlh2 complex and tested its ability to be recruited
to mispair-bound Msh2-Msh6 or Msh2-Msh3 using a previously
developed surface plasmon resonance assay [48]. As previously
demonstrated [48], Msh2-Msh6 has low affinity for a substrate
lacking a mispair (the ‘GC’ substrate) and a higher affinity for
substrates with a central T:G mispair (the ‘TG’ substrate) or a +T
insertion (the ‘+1’ substrate) (Figure 4A–C). As expected, Mlh1-
Pms1 readily bound Msh2-Msh6 on all of these substrates and the
increase in resonance units correlated with the amount of pre-
bound Msh2-Msh6. Msh2-Msh6 also recruited Mlh1-Mlh2 and,
similar to Mlh1-Pms1, the increase in resonance units correlated
with the amount of pre-bound Msh2-Msh6 (Figure 4A–C).
However, the kinetics of Mlh1-Mlh2 recruitment differed from
Mlh1-Pms1 in that initial binding was slower and the binding
failed to saturate. Msh2-Msh3 had a low affinity for both the GC
and TG substrates, but bound well to the +1 substrate (Figure 4D–
F), consistent with the function of MSH3 in the repair of insertion/
deletion mispairs and an inability to function in the repair of many
kinds of base-base mispairs [46,49,50]. As seen with Msh2-Msh6,
both Mlh1-Pms1 and Mlh1-Mlh2 were recruited to substrates
bound by Msh2-Msh3 with the level of recruitment correlating
with the amount of Msh2-Msh3 bound (Figure 4D–F). The ability
of Msh2-Msh3 to recruit Mlh1-Pms1 was consistent with the fact
that Pms1 foci form in msh6D and msh3D strains but not in msh2D
and msh3D msh6D strains and with our previous study demon-
strating the recruitment of Mlh1-Pms1 to mispair-containing DNA
by Msh2-Msh3 in vitro [33,51]. Overall, these results support the
Figure 3. Pms1 and Mlh2 foci are induced upon treatment with
phleomycin but not hydroxyurea and do not colocalize with
DNA double-strand breaks. (A) Phleomycin, but not hydroxyurea,
increases the number of Pms1-46GFP and Mlh2-46GFP foci in an
MSH2-dependent manner. ‘‘n’’ indicates the numbers of live cells
examined. (B) Images of cells expressing Mre11-GFP, Pms1-46GFP, or
Mlh2-46GFP in a strain expressing TetR-mRFP and containing a tandem
array of tetO sequences adjacent to an I-SceI restriction site after
induction of I-SceI reveal that Mre11, but not Pms1 or Mlh2, colocalizes
with the double-strand break. (C) Quantitation of cells containing
Mre11, Pms1, and Mlh2 foci and their colocalization with the tetO array
with and without I-SceI induction.
doi:10.1371/journal.pgen.1004327.g003
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idea that Mlh1-Mlh2 can function in conjunction with both Msh2-
Msh3 and Msh2-Msh6, although the extent of involvement of
Mlh2 may depend on the assay used and hence the exact MMR
substrate being acted on.
Overexpression of Mlh2 and Mlh3, but not Pms1, causes
MMR defects
Because MLH2 lacks conserved endonuclease motifs and
mutations abolishing pms1 endonuclease function cause a weakly
dominant MMR defect that is enhanced by overexpression [13],
we tested if overexpression ofMLH2 would cause an MMR defect.
We therefore engineered S. cerevisiae strains in which the
endogenous promoters of the MLH2, MLH3 and PMS1 genes
were replaced by the strong promoter of the glyceraldehyde 3-
phosphate dehydrogenase gene (pGPD) and monitored these
strains for mutator phenotypes using the hom3-10 and lys2-10A
frameshift reversion assays and the CAN1 forward mutation assay.
Overexpression of PMS1 did not cause increased mutation rates;
however, overexpression of MLH2 or MLH3 drastically increased
the mutation rates up to levels that were almost indistinguishable
from an MMR defective strain (msh3D msh6D) (Table 2). Similar
results were obtained upon the expression of these genes driven by
their native promoters on high copy number plasmids in wild-type
cells (data not shown). The endogenous expression level of Pms1
was roughly 5–10-fold higher than that of either Mlh2 or Mlh3
(Figure 5A), and the pGPD promoter increased the expression of
each MutL homolog by .50-fold relative to the endogenous level
of Pms1 (Figure 5B). The mismatch repair defect caused by the
overexpression of MLH2 was largely suppressed by the simulta-
neous overexpression of PMS1 (Table 2). These data suggest that
increasing the level of Mlh2 or Mlh3 by overexpression allows
Mlh2 or Mlh3 to outcompete Pms1 for binding to the Mlh1
present in the cell, thereby preventing the formation of sufficient
levels of Mlh1-Pms1 complex to support MMR, and that neither
Mlh2 nor Mlh3 is sufficient to replace Pms1 function in MMR. In
the case of Mlh1-Mlh2, this is most likely because Mlh1-Mlh2
lacks endonuclease activity. In the case of Mlh1-Mlh3, it is possible
that Mlh1-Mlh3 lacks sufficient endonuclease activity to substitute
for Mlh1-Pms1 or it does not function sufficiently in the Msh2-
Msh6 pathway to promote MMR [21]. It is also possible that
overexpression leads to much higher levels of Mlh1-Mlh2 or
Mlh1-Mlh3 complexes, which then outcompete the Mlh1-Pms1
complex for a key substrate.
Mlh2 is a widely conserved MutL homolog lacking
endonuclease motifs
Because S. cerevisiae MLH2 plays only an accessory role in
MMR, we examined the conservation of MLH2. We first
identified MutL homologs using BLAST [52] in the Sacchar-
omycotina subphylum of Ascomycota, which includes S. cerevisiae.
Obvious homologs of MLH1, PMS1, MLH3, and MLH2 were
identified (Figure 6 and S2; Table S1) by reciprocal BLAST, by
analysis of conserved synteny [53], and/or by the characteristic C-
terminal sequence motifs of MLH1, PMS1, and MLH3 involved in
endonuclease activity. The origin of MLH2 predated the whole-
genome duplication that occurred ,100 million years ago and led
to S. cerevisiae and related yeasts [54], because MLH2 homologs
were present in species that diverged from S. cerevisiae prior to the
genome duplication and two MLH2 ohnologs (paralogs produced
by the whole-genome duplication [55,56]) were present in
Vanderwaltozyma polyspora. A few clades in Saccharomycotina have
lost MLH2, including the ‘CTG’ yeast that encode serine instead
of leucine with the codon CTG [57] and species in the Lachancea
genus (Figure S2, Table S1).
We also identified MutL homologs in other sequenced fungi
(Figure 6, Table S1).MLH1, PMS1, MLH3, and MLH2 genes were
found in the Pezizomycotina subphylum of Ascomycota, but the
early diverging Taphrinomycotina subphylum, which includes
Table 1. Mutation rate analysis of mlh2D in combination with mismatch repair mutations.
Mutation rate (fold increase)a
Relevant genotype RDKY Thr+ Lys+ CanR
A wild-type 5964 2.5 [1.8–3.8]61029 (1) 1.5 [1.0–5.0]61028 (1) 6.8 [3.9–8.7]61028 (1)
mlh2D 7926 5.5 [3.0–8.4]61029 (2) 3.1 [1.3–4.0]61028 (2) 6.1 [4.2–11.7]61028 (1)
msh6D 7965 9.9 [8.7–18.9]61029 (4) 4.1 [2.9–7.2]61027 (27) 5.1 [4.3–8.6]61027 (8)
msh3D 6051 3.1 [2.0–4.2]61028 (12) 1.2 [1.0–3.1]61027 (8) 1.2 [0.7–4.5]61027 (2)
exo1D 7884 1.2 [0.5–3.0]61028 (5) 1.0 [0.5–1.7]61028 (7) 7.7 [5.9–13]61027 (11)
mlh2D msh3D 7923 9.0 [7.3–15.1]61029 (4) 8.3 [3.9–12.8]61028 (6) 7.5 [3.9–9.6]61028 (1)
mlh2D msh6D 7924 8.5 [3.5–12.4]61028 (34) 2.7 [1.2–3.9]61026 (178) 7.0 [2.7–12.0]61027 (10)
mlh2D exo1D 7925 6.7 [4.0–16.1]61029 (3) 8.2 [3.4–22.2]61028 (5) 3.8 [2.0–4.7]61027 (6)
msh3D msh6D 6098 5.1 [2.9–13]61026 (2040) 3.4 [2.0–5.0]61025 (2267) 2.0 [0.8–5.6]61026 (29)
B tetO2-PMS1 (YPD) 8160 3.0 [1.5–5.9]610
29 (1) 3.2 [1.9–4.6]61028 (2) 4.4 [3.4–8.4]61028 (1)
tetO2-PMS1 (+Dox) 8160 4.0 [2.5–5.8]61028 (16) 1.3 [0.9–1.5]61026 (89) 1.0 [0.9–1.4]61027 (2)
mlh2D (YPD) 8159 1.0 [0.7–2.4]61028 (4) 7.9 [3.8–10.1]61028 (5) 1.0 [0.3–1.5]61027 (2)
mlh2D (+Dox) 8159 6.0 [5.3–14.1]61029 (2) 6.9 [3.8–11.3]61028 (5) 1.1 [0.7–1.6]61027 (2)
tetO2-PMS1 (YPD) mlh2D 8161 5.2 [4.0–8.4]610
29 (2) 1.4 [0.7–1.7]61027 (9) 4.3 [2.7–5.6]61028 (1)
tetO2-PMS1 (+Dox) mlh2D 8161 1.2 [1.0–1.7]61027 (48) 3.1 [2.5–4.0]61026 (207) 1.7 [1.4–2.0]61027 (3)
aMedian rates of hom3-10 and lys2-10A reversion and inactivation of the CAN1 gene with the 95% C.I. in square brackets and fold increase relative to the wild-type in
parentheses.
tetO2-PMS1, PMS1 driven by the tetO2 promoter; Dox, doxycycline.
doi:10.1371/journal.pgen.1004327.t001
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Schizosaccharomyces pombe, only contained MLH1 and PMS1. In a
small number of species, the MLH2 homologs contained stop
codons and frameshifts, which could reflect errors in the genome
sequences, loss of non-essential portions ofMLH2 or inactivation of
the MLH2 homologs (Table S2). MLH2 homologs were also not
identified in Basidiomycetes but were observed in the basal fungi
Mucor circinelloides (Mucoromycotina) and Allomyces macrogynus
(Blastocladiomycota), which was consistent with the loss of MLH2
in Basidiomycetes rather than the gain of MLH2 in Ascomycetes.
Phylogenetic analysis of the full-length Mlh2 protein sequences was
consistent with the major divisions within fungi (Figure S3).
S. cerevisiae MLH2 has a number of similarities to metazoan
PMS1 (note that PMS2 in metazoans is the name for the homolog
of S. cerevisiae PMS1). Like S. cerevisiae MLH2, metazoan PMS1 lacks
endonuclease motifs and does not support MMR reactions in vitro
[58,59], and deletion of metazoan PMS1 causes an extremely weak
mutator phenotype [60]. To examine the relationship between
metazoan Pms1 and fungal Mlh2, we performed phylogenetic
analysis on the sequences of the N-terminal domains of MutL
homologs from select unikont species (Figure S4). This analysis
identified distinct clades with strong support (clade credibility
scores of 100%) for the homologous human PMS2 and fungal
Pms1 proteins, human MLH3 and fungal Mlh3 proteins, as well as
the human PMS1 and fungal Mlh2 proteins. Thus, this analysis
suggests that human PMS1 is evolutionarily related to fungal Mlh2
and that the accessory MMR function is conserved across diverse
eukaryotes (Figure 6).
Discussion
In this study, we demonstrated that both Pms1 andMlh2 form foci
that often colocalize and that the formation of these foci depends
upon Mlh1, Msh2-Msh6 and, in the case of Pms1, can also be
promoted by Msh2-Msh3 [33]. The frequency of both types of foci
increase in strains with increased mispair formation or defects in the
downstream steps of MMR. In contrast, no Mlh3 foci were detected
despite the fact that Mlh3 was expressed at levels similar to Mlh2.
Deletion ofMLH2 did not cause a significant increase in the mutation
rate in frameshift reversion assays unless Pms1 levels were reduced,
and an MLH2 deletion synergized with a deletion of MSH6, but not
with a deletion of MSH3. In vitro, both Msh2-Msh6 and Msh2-Msh3
could recruit Mlh1-Mlh2 to mispair-containing DNA. These results
are consistent with a role for Mlh2 in MMR. However, the lack of
endonuclease motifs in Mlh2 suggests that its ability to promote
MMR must involve mechanisms other than Mlh1-Mlh2-mediated
cleavage of DNA. Together, these data suggest that Mlh1-Mlh2 acts
as an MMR accessory or stimulatory factor that functions in
conjunction with Mlh1-Pms1.
The studies performed here could be taken to present an apparent
discrepancy in the placement of MLH2 in known MMR sub-
Figure 4. Msh2-Msh6 and Msh2-Msh3 can recruit Mlh1-Pms1 and Mlh1-Mlh2 to mispaired bases. (A–C) Recruitment of Mlh1-Pms1 or
Mlh1-Mlh2 by Msh2-Msh6 to (A) homoduplex DNA, (B) DNA containing a central TG mispair, and (C) DNA containing a central +T insertion. (D–F)
Recruitment of Mlh1-Pms1 or Mlh1-Mlh2 by Msh2-Msh3 to (D) homoduplex DNA, (E) DNA containing a central TG mispair, and (F) DNA containing a
central +T insertion. Binding of Msh2-Msh6 or Msh2-Msh3 was monitored by surface plasmon resonance for 100 seconds (black lines), following
which Mlh1-Pms1 (orange lines) or Mlh1-Mlh2 (blue lines) or no MutL homolog (dashed black line) was included in the binding reaction. Increases in
resonance units (RU) indicate the binding of the proteins to the DNA on the chip. The curves shown were obtained after subtraction of the signals
from the reference flow cell as well as the signals obtained by Mlh1-Pms1 or Mlh1-Mlh2 binding to the DNA alone, which did not exceed 10 to 20% of
the signal attributable to recruitment of Mlh1-Pms1 or Mlh1-Mlh2 by Msh2-Msh6 or Msh2-Msh3.
doi:10.1371/journal.pgen.1004327.g004
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pathways. The genetics of foci formation suggest that Mlh2
recruitment is primarily mediated by Msh2-Msh6 but not Msh2-
Msh3, whereas the frameshift reversion assays indicate the involve-
ment of MLH2 in MSH3-dependent but not MSH6-dependent
MMR. In contrast, the ability of Mlh1-Mlh2 to be recruited to
mispair-containing DNA in vitro by both Msh2-Msh6 and Msh2-
Msh3 is consistent with a role for Mlh2 in both pathways. One
potential explanation for this apparent discrepancy is that Mlh2 plays
a role in both pathways, but the recruitment and function of Mlh1-
Mlh2 in MMR are highly dependent on the type of mispair that is
recognized. The relative contribution of Mlh1-Mlh2 to repair may be
influenced by the sequence context of the mispair and whether repair
occurs by substitution, deletion or insertion. Thus, the different assay-
dependent activities of Mlh1-Mlh2 observed could reflect the fact that
the three different assays used in our studies all by necessity use
different mispaired substrates. Additionally, the in vitro mispair-
dependent Mlh1-Mlh2 recruitment assays use different ratios of
Msh2-Msh6 and Msh2-Msh3 than present in cells, resulting in
different apparent efficiencies of recruitment of Mlh1-Mlh2 byMsh2-
Msh6 and Msh2-Msh3 in vitro and in vivo. These types of differential
activities have been clearly documented in the case of theMlh1-Mlh3
complex [21–23,25,28].
We propose the following hypothesis for the role of Mlh2 in
MMR. The Mlh1-Mlh2 complex may have some functional
overlap with the non-endonuclease functions of the Mlh1-Pms1
complex in MMR such as recruitment of downstream MMR
components and discrimination of the newly synthesized DNA
strand, allowing MMR to occur at lower levels of Mlh1-Pms1 at
the sites of repair. This role of Mlh1-Mlh2 in reducing the
requirement for Mlh1-Pms1 while not being able to replace the
activity of Mlh1-Pms1 suggests that Mlh1-Mlh2 acts as a non-
essential accessory or stimulatory factor in MMR. It is also possible
that Mlh1-Mlh2 in some way regulates the availability or activity
of Mlh1-Pms1. Because the Mlh1-Pms1 endonuclease activity is
essential for MMR in vivo, this hypothesis suggests that it might be
possible to reveal these Mlh2 functions through the isolation of
separation-of-function mutations in Pms1 that eliminate MMR in
the absence of Mlh2 but leave the endonuclease activity of Mlh1-
Pms1 intact. In addition, this hypothesis predicts that Mlh1-Pms1
and Mlh1-Mlh2 might be loaded onto the same DNA substrate, as
suggested by the colocalization observed between Pms1 and Mlh2
foci as well as the accumulation of Mlh2 foci in the absence of
Mlh1-Pms1 endonuclease activity; future studies will be required
to determine if both complexes are recruited to the same mispaired
substrate and if this is functionally significant. Our results are
reminiscent of bacteriophage Lambda site-specific recombination
where the biochemical requirement for the FIS protein during
excision in vitro, which acts as an accessory factor, could only be
revealed at sub-optimal levels of XIS protein [61].
Our studies have provided strong evidence that S. cerevisiae Mlh2
is the homolog of mammalian PMS1. Mammalian PMS1 is known
to form a complex with MLH1, although the possible role of
mammalian PMS1 in MMR is unclear [58,60]. Consequently, the
results described here may also provide new insights into a possible
role of the mammalian MLH1-PMS1 complex in MMR. In
addition, the ability of S. cerevisiae Mlh1-Mlh2 to be recruited by
mispairs and the mutator phenotype caused by overexpression of
MLH2 (and MLH3) suggests that increased expression of human
PMS1 (or human MLH3) might represent a mechanism that could
lead to MMR inactivation and promote tumorigenesis, analogous
to MMR defects in Lynch Syndrome and other types of sporadic
cancer characterized by microsatellite instability [1,3–5].
Materials and Methods
Media and strains
S. cerevisiae strains were grown at 30uC in yeast extract-peptone-
dextrose media (YPD) or appropriate dextrose-containing synthet-
ic dropout media for selection of Lys+ or Thr+ revertants or
canavanine-resistant (CanR) mutants. All strains used for mutation
analyses in this study (Table S3) were derivatives of the S288c
strain RDKY3686 (MATa ura3-52 leu2D1 trp1D63 his3D200 hom3-
10 lys2-10A) [62]. Strains used for the colocalization experiments
with the inducible I-SceI-generated double strand break contained
the pGAL-I-SceI construct, the I-SceIcs restriction site adjacent to the
3xURA3-tetOx112 array, and TetR-mRFP derived from W9561-17A
[63] (generously provided by R. Rothstein, Columbia Medical
School).
Gene deletion, tagging and promoter replacements for gene
overexpression (pGPD) were performed using standard PCR-based
recombination-mediated gene targeting methods [64] followed by
confirmation with PCR. The correct insertion of tags/promoters and
the absence of additional mutations were confirmed by sequencing.
Strains expressing Pms1 under the tetracycline repressible
promoter (tetO2) were generated as previously described [47].
The parental strain (RDKY8158) containing the chimeric
repressor (tetR9-SSN6), the transactivator (tTA) and the MMR
reporters (lys2-10A and hom3-10) was obtained after mating
RDKY3686 with the CML476 strain (MATa ura3-52 leu2D1
his3D200 GAL2 CMVp(tetR9-SSN6)::LEU2 trp1::tTA (Euroscarf).
Plasmid pCM324 (Euroscarf) was used to introduce the tetO2
promoter immediately upstream of the Pms1 start codon.
Table 2. Mutation rate analysis of strains overexpressing Pms1, Mlh2 or Mlh3.
Relevant genotype RDKY Mutation rate (fold increase)
a
Thr+ Lys+ CanR
wild-type 5964 2.5 [1.8–3.8]61029 (1) 1.5 [1.0–5.0]61028 (1) 6.8 [3.9–8.7]61028 (1)
pGPD-PMS1 7897 1.0 [5.3–17.0]61028 (4) 8.7 [7.1–14.9]61028 (6) 8.4 [6.1–13.9]61028 (1)
pGPD-MLH2 7895 2.4 [1.6–5.4]61026 (968) 5.8 [4.5–6.9]61025 (3848) 1.6 [1.3–2.1]61026 (23)
pGPD-MLH3 7896 1.7 [1.1–2.6]61026 (667) 5.7 [3.4–8.3]61025 (3821) 1.3 [1.1–2.4]61026 (19)
pGPD-(MLH2 + PMS1) 7904 2.8 [2.0–5.7]61028 (11) 7.4 [5.3–15.9]61027 (49) 9.9 [7.9–12.2]61028 (1)
msh3Dmsh6D 6098 5.1 [2.9–13]61026 (2040) 3.4 [2.0–5.0]61025 (2267) 2.0 [0.8–5.6]61026 (29)
aMedian rates of hom3-10 and lys2-10A reversion and inactivation of the CAN1 gene with the 95% C.I. in square brackets and fold increase relative to the wild-type in
parentheses.
doi:10.1371/journal.pgen.1004327.t002
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Specific point mutations were introduced in chromosomal
genes using standard integration/excision methods and the
following integrating plasmids: msh6-F337A was introduced
with pRDK1602 [33]; pms1-E707K was introduced with
pRDK1583 [33]; and the DNA polymerase alleles pol2-
M644G, pol3-01, and pol3-L612M were integrated as previously
described [35,37,65,66]. The presence of the desired mutation
and absence of additional mutations was confirmed by DNA
sequencing.
For visualization of the low abundance proteins Pms1 and
Mlh2, we tagged them at the C-terminus at the endogenous gene
locus with four tandem copies of GFP (46GFP) using the
pSM1023 plasmid (gift of E. Schiebel, University of Heidelberg).
Testing of the tagged strain RDKY7893 (MLH2-4GFP.KanMX6)
for sensitivity to cisplatin as described previously [30] showed that
it had the same sensitivity as the wild-type parental strain
RDKY5964 and was more sensitive than the mlh2D control strain
RDKY7926 (mlh2::KanMX4), indicating that the tag on the C-
terminus of Mlh2 was unlikely to have an effect on Mlh2 function
[30]. The nuclear pore protein Nic96 was tagged at the C-
terminus with mCherry using the plasmid pBS35 as a template
(Yeast Resource Center YRC). The C-terminus of Mlh2 was
tagged with tdTomato using a PCR-based strategy and the
plasmid pRDK1663. This plasmid was derived from pYM25
yeGFP.hphNT1 (Ref. [64]; obtained from Euroscarf) by excising the
HindIII-BglII fragment containing the yeGFP coding sequence,
replacing it with a HindIII-BglII fragment (generated by gene
synthesis at Integrated DNA Technologies, IDT) encoding an S.
cerevisiae codon optimized tdTomato gene and a linker (Gly Ala)5
immediately upstream of the Met start codon of tdTomato.
Immunoblotting
S. cerevisiae whole-cell extracts were prepared using the Yeast
Extract Buffer (1.85 M NaOH, 7.5% beta-mercaptoethanol), and
the soluble proteins were precipitated by addition of an equal
volume of 50% trichloroacetic acid. The protein extracts were
analyzed by SDS-PAGE using 4%–15% gradient gels (BioRad)
and immunoblotting. Detection of GFP-tagged proteins was
performed using the anti-GFP antibody, clone B34 (Covance).
Using the anti-Pgk1 antibody (clone 22C5D8; Invitrogen), Pgk1
expression was monitored as a loading control. MYC-tagged
proteins were detected with the monoclonal anti-MYC antibody
(clone 4A6; Millipore).
Genetic assays
Mutation rates were determined using the hom3-10 and lys2-10A
frameshift reversion assays and CAN1 inactivation assay by
fluctuation analysis [67] as previously described [46,62]. The
mutation rates presented in Table 1B were determined in the
absence or presence of 10 mg/ml of doxycycline (present in liquid
cultures as well as in agar plates).
Protein purification
All the proteins were expressed from plasmid expression vectors
in either E. coli or S. cerevisiae as indicated below. Typical yields
ranged from 100 mg to 500 mg per liter of expressing cells. All the
protein preparations were confirmed to be greater that 95% pure
as judged by SDS-PAGE followed by staining of the resulting gels
with Coomassie Blue.
Purification of Mlh1-Pms1. S. cerevisiae Mlh1-Pms1 was
overexpressed in S. cerevisiae and purified according to a previously
published procedure using an overexpression strain derived by the
transformation of RDKY1293 (MATa, ura3-52, leu2D1, trp1,
his3D200, pep4::HIS3, prb1D1.6R, can1) with the plasmids
pRDK573 (pGAL1-10-MLH1 TRP1) and pRDK1099 (pGAL1-10-
PMS1-FLAG LEU2) [13,68].
Purification of Mlh1-Mlh2. S. cerevisiae Mlh1-Mlh2 was
overexpressed in the S. cerevisiae strain RDKY8153 that was
generated by transformation of RDKY1293 (MATa, ura3-52,
leu2D1, trp1, his3D200, pep4::HIS3, prb1D1.6R, can1) with the
plasmids pRDK573 (pGAL1-10-MLH1 TRP1) and pRDK1664
(pGAL1-10-Mlh2-FLAG LEU2). pRDK1664 was generated by
replacement of the PMS1 ORF with MLH2 using gap-repair.
Figure 5. Expression of Pms1, Mlh2 and Mlh3 under control of
the endogenous and pGPD promoters. (A) Expression level of
Mlh2-9MYC, Mlh3-9MYC, and Pms1-9MYC driven from their endoge-
nous promoters monitored by immunoblotting with an anti-MYC
antibody. Immunoblotting with an anti-Pgk1 antibody was used a
loading control. (B) Comparison of the levels of Mlh2-9MYC, Mlh3-
9MYC, and Pms1-9MYC by immunoblotting with an anti-MYC antibody
when expressed from the endogenous promoter or the pGPD promoter.
Bottom panel, comparison after 50-fold dilution of the pGPD samples.
doi:10.1371/journal.pgen.1004327.g005
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Briefly, pRDK1099 was linearized with SphI and used to co-
transform wild-type S. cerevisiae with a PCR product containing the
MLH2 ORF and flanking sequences homologous to the pGAL1-10
promoter and FLAG at the 59 and 39 end, respectively.
Gap-repaired plasmids were recovered from Leu+ transformants
and verified by sequencing.
The overexpressing strain RDKY8153 was grown as previously
described for the purification of Mlh1-Pms1 [69]. A 100 ml
culture was harvested by centrifugation for 10 min at 3,000 rpm
in a swinging bucket rotor in a Sorvall Legend RT centrifuge at
20uC and then the cells were resuspended in 25 ml of Buffer A200
[50 mM Tris-Cl (pH 8.0), 10% glycerol, 200 mM NaCl, 2 mM b-
mercaptoethanol, protease inhibitor mixture PIC D (final concen-
trations of 1 mM phenylmethanesulfonyl fluoride (PMSF), 1 mg/L
chymostatin, and 1 mg/L pepstatin A) and protease inhibitor
mixture PIC W (final concentrations of 1 mM benzamidine,
0.5 mg/L bestatin, 1 mg/L aprotinin, and 1 mg/L leupeptin)] at
4uC. Then, 4 ml of Cell Lytic Y Cell Lysis Reagent (Sigma) was
Figure 6. Evolutionary conservation of MutL homologs. The presence of a conserved MLH1, S. cerevisiae PMS1/human PMS2, MLH3, and S.
cerevisiae MLH2/human PMS1 homolog in sequenced unikont genomes is indicated by a ‘Y’. ‘N’ indicates the lack of an identifiable homolog. MLH1
and ScPMS1/hPMS2 are extensively conserved, whereas MLH3 and ScMLH2/hPMS1 are less well conserved. Alternating light and dark grey
backgrounds indicate separations between major unikont groups (Fungi, Nucleariidae and Fonticula, Ichthyosporea, Choanoflagellata, Metazoa,
Apusozoa, and Amoebozoa).
doi:10.1371/journal.pgen.1004327.g006
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added to the resuspended cells, and the cells were distributed into
1 ml aliquots in microcentrifuge tubes. The tubes were rocked for
45 min at 4uC, and then the cells were sonicated for 25 s with a 5-s
pulse on and a 1-s pulse off for three cycles. The tubes were then
centrifuged at 14,000 rpm in a tabletop Eppendorf centrifuge for
30 min at 4uC, and the supernatants were pooled. Then, 4 ml of
FLAG antibody resin equilibrated in Buffer A200 was added to the
pooled supernatant, and the resulting suspension was rocked for
1 hr at 4uC. The resin was then poured into a column that was
washed 5 times with 1 ml of buffer A200, and then the protein was
washed 7 times with 1 ml of buffer A200 containing 200 mg/ml of
FLAG peptide. Fractions containing the protein were pooled and
concentrated as previously described [13], and then aliquots were
frozen in liquid nitrogen and stored at 280uC.
Purification of Msh2-Msh6. S. cerevisiae wild type Msh2-
Msh6 was overexpressed in E. coli BL21 (DE) RIL using the
pET11 MSH2-MSH6 plasmid and purified according to a
previously published procedure [70,71].
Purification of Msh2-Msh3. S. cerevisiae Msh2-Msh3 was
expressed in S. cerevisiae RDKY2418 MATa, ura3-52, leu2D1, trp1,
his3D200, pep4::HIS3, prb1D1.6R, can1, msh2::hisG, msh6::hisG [72]
transformed with the expression plasmids pRDK354 (pGAL1-10-
MSH2 URA3) and pRDK1596 (pGAL1-10 MSH3-FLAG LEU2)
and purified as described previously [51].
Surface plasmon resonance analysis
The recruitment of Mlh1-Pms1 or Mlh1-Mlh2 by Msh2-Msh6
or Msh2-Msh3 bound to DNA was analyzed using a Biacore T100
instrument essentially as described previously [13,68]. Biotinylated
236 bp-long double-stranded DNAs containing the terminal lacO
sequence and a central TG mispair, +T insertion or GC base pair
were conjugated to 3 flow cells of a streptavidin-coated Biacore SA
chip (GE Healthcare) to obtain a signal of ,100 Resonance Units
(RU). The signal from the unmodified flow cell was used for
reference subtraction in all experiments. A constant flow rate of
20 ml/min was maintained and experiments were performed at
25uC. First, 30 nM purified LacI tetramer (a gift from Kathleen
Matthews, Rice University) in reaction buffer (25 mM Tris-Cl
(pH 8.0), 4 mM MgCl2, 110 mM NaCl, 0.01% Igepal, 2 mM
DTT and 2% glycerol) was injected over the chip for 60 s. Next, at
time t = 0 a sample containing 30 nM LacI, 20 nMMsh2-Msh6 or
20 nM Msh2-Msh3 and 250 mM ATP in reaction buffer was
injected for 100 s, followed by the immediate injection of a sample
containing the same mixture and in addition 40 nM Mlh1-Pms1
or 40 nM Mlh1-Mlh2, or no MutL homolog for 150 s. The chip
surface was regenerated using a 60 s pulse of 2 M NaCl. Control
experiments were performed in which the first injection consisted
of 30 nM LacI, the sond injection consisted of 30 nM LacI and
250 mM ATP, and the third injection consisted of 30 nM LacI,
250 mM ATP and either 40 nM Mlh1-Pms1 or 40 nM Mlh1-
Mlh2. These data were subtracted from the data obtained using
Msh2-Msh6/Msh2-Msh3 in the second and third injections, and
the subtracted curves are presented. Data were analyzed using the
BiaEvaluation 2.0.3 (GE Healthcare) and Prism 6.0 software
(GraphPad).
Live-cell imaging and image analysis
Exponentially growing cultures were washed and resuspended
in water and placed on minimal media agar pads, covered with a
coverslip, and sealed with valap (a 1:1:1 mixture of Vaseline,
lanolin, and paraffin by weight). Cells were imaged on a
Deltavision (Applied Precision) microscope with an Olympus
10061.35NA objective. Fourteen 0.5 mm z sections were acquired
and deconvolved with softWoRx software. For time-lapse imaging
of Pms1 foci, images were collected every min with fewer z sections
to minimize photobleaching. Further image processing, including
maximum intensity projections and intensity measurements, was
performed using ImageJ.
For drug treatments, cells that were growing logarithmically in
YPD medium were treated with either 200 mM hydroxyurea or
5 mM phleomycin for 3 hr and prepared for microscopy as
described above. Cell cycle arrest was confirmed by examining cell
morphology using a microscope. For DSB induction by I-SceI,
strains RDKY7906, RDKY7907, and RDKY7908 were grown
overnight in medium containing 2% raffinose. The cultures were
diluted into the same medium and after 3 hr, pelleted and
resuspended in medium containing either 2% raffinose or 2%
galactose, incubated at 30uC for 2.5 hr, and prepared for
microscopy.
Foci were considered to be colocalized if over half of their
diameters overlapped. Colocalization was scored if at least one
focus per nucleus displayed colocalization in the same z section.
Images with the same fluorescent fusion protein in the same figure
have identical contrast adjustment. The data presented here
contain representative images and quantitative data from at least
two independent experiments, each performed using two inde-
pendent strain isolates, which gave similar results. The total
number of cells/nuclei (n) analyzed for each strain is indicated.
Phylogenetic analysis
MutL homologs were identified using Protein BLAST [52]
against the non-redundant protein sequences (nr) database. For
some MutL homologs, alignments of the protein sequences
revealed that strongly conserved regions were missing. We
analyzed the genomic sequences encoding these genes and
discovered that these were often due to incorrect assignment of
exons, as the missing regions tended to either be at exon
boundaries, suggesting the inappropriate identification of a
predicted splice site, or in introns, suggesting the failure to identify
an exon. For these genes, we re-annotated the exons, typically
merging in-frame introns with the surrounding exons or identi-
fying missing exon sequences, and retranslated the protein
sequences (Table S2). The criteria for re-annotation of the exons
were to improve homology to the conserved portions of the protein
sequence alignment and maintain conservation of the intron/exon
structure with closely related species. In some cases, a frameshift or
stop codon was present in an exon. In these cases, the surrounding
protein sequence was translated to prevent truncations from
having an inordinately large effect on the phylogenetic analysis;
however, this analysis could not distinguish between sequencing
errors or species having mutations that inactivated the gene. The
cases in which a protein was translated in spite of frameshifts or
stop codons in the reference genomic sequence are explicitly
labeled in Table S2. To decipher relationships between MutL
homologs, amino acid sequences of the N-terminal domains were
aligned with MAFFT [73] to avoid misalignments due to effects of
the rapidly evolving and likely unstructured linker between the
MutL N- and C-terminal domains. Phylogenetic analyses were
performed with MrBayes [74] using the mixed amino acid rate
matrices model and 1,000,000 generations. Clade credibility
values above 75 were considered significant.
Supporting Information
Figure S1 Downregulation of S. cerevisiae Pms1 expression upon
addition of doxycycline. Expression levels of Pms1 (tagged with
9MYC) of strains containing the repressible tetO2-Pms1 promoter
(lanes 1+2) or the endogenous Pms1 promoter (lanes 3+4). Cells
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were grown for 3 hours in YPD in the presence (or absence) of
10 mg/ml of doxycycline, as indicated. Whole-cell extracts were
prepared and analyzed by SDS-PAGE and immunoblotting. The
anti-Myc antibody was used to detect Pms1 expression and Pgk-1
was used as a loading control. Relates to Table 1.
(EPS)
Figure S2 Conservation of MLH1, MLH2, MLH3, and PMS1 in
species of Saccharomycotina with sequenced genomes. ‘WGD
clade’ indicates the group of species that have undergone whole-
genome duplication. ‘CTG clade’ indicates the group of species
that encode serine instead of leucine with the CTG codon.
Phylogenetic relationships between species were derived from
previously published analyses [75–77].
(EPS)
Figure S3 Clustering of the full-length Mlh2 sequences from
fungi. This phylogenetic analysis reconstructed the Saccharomy-
cotina and Pezizomycotina subphyla within Fungi as well as class
and family relationships, consistent with homology between fungal
MLH2 genes. Clade support values of 75 or higher are indicated
on the phylogenetic tree.
(EPS)
Figure S4 Clustering of sequences of the N-terminal domains of
MutL homologs from sequenced unikont species provided clear
support for the homology of S. cerevisiae MLH2 and human PMS1,
S. cerevisiae MLH3 and human MLH3, as well as S. cerevisiae PMS1
and human PMS2. Clade support values of 75 or higher are
indicated on the phylogenetic tree.
(EPS)
Table S1 MutL homologs in sequenced unikont genomes.
(XLS)
Table S2 Re-annotation of MutL genes in fully sequenced
genomes.
(DOCX)
Table S3 S. cerevisiae strains used in this study.
(DOCX)
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